Fischer Medical Ventures Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	2,600	1,107	209.81	1.8	-	1.65
Revenue	2,600	1,107	209.81	1.8	-	1.65
Revenue Growth (YoY)	215.87%	427.61%	11588.75%	-	-	-10.28%
Cost of Revenue	1,640	917.59	165.76	-	-	0.8
Gross Profit	959.75	189.4	44.05	1.8	-	0.85
Selling, General & Admin	141.27	47	5.11	0.63	0.9	-
Other Operating Expenses	372.38	108.97	20.35	1.01	0.98	1.03
Operating Expenses	539.28	172.29	27.27	1.64	1.89	1.03
Operating Income	420.47	17.11	16.78	0.15	-1.89	-0.18
Interest Expense	-23.88	-4.03	-0.68	-0.17	-0.09	-0.18
Interest & Investment Income	9.27	9.27	4.95	-	-	-
Earnings From Equity Investments	-3.14	-4.87	-	-	-	-
Other Non Operating Income (Expenses)	99.58	2.65	0.06	-0	-	-
EBT Excluding Unusual Items	502.3	20.14	21.11	-0.01	-1.97	-0.36
Pretax Income	504.38	22.23	21.11	-0.01	-1.97	-0.36
Income Tax Expense	109.87	10.15	2.73	0.35	0.35	-1.76
Net Income	394.51	12.08	18.38	-0.37	-2.33	1.41
Net Income to Common	394.51	12.08	18.38	-0.37	-2.33	1.41
Net Income Growth	1947.06%	-34.28%	-	-	-	-
Shares Outstanding (Basic)	934	670	111	2	2	2
Shares Outstanding (Diluted)	943	670	169	2	2	2
Shares Change (YoY)	60.37%	295.30%	9752.91%	-	-	-
EPS (Basic)	0.42	0.02	0.17	-0.21	-1.35	0.82
EPS (Diluted)	0.42	0.02	0.11	-0.21	-1.35	0.82
EPS Growth	1181.56%	-83.31%	-	-	-	-
Free Cash Flow	-	-927.26	-78.37	-1.46	-1.77	-0.57
Free Cash Flow Per Share	-	-1.38	-0.46	-0.85	-1.03	-0.33
Dividend Per Share	-	0.005	-	-	-	-
Gross Margin	36.91%	17.11%	20.99%	100.00%	-	51.76%
Operating Margin	16.17%	1.55%	8.00%	8.52%	-	-10.67%
Profit Margin	15.17%	1.09%	8.76%	-20.33%	-	85.21%
Free Cash Flow Margin	-	-83.76%	-37.35%	-81.28%	-	-34.73%
EBITDA	431.3	23.69	17.68	-	-	-
EBITDA Margin	16.59%	2.14%	8.43%	-	-	-
D&A For EBITDA	10.84	6.58	0.91	-	-	-
EBIT	420.47	17.11	16.78	0.15	-1.89	-0.18
EBIT Margin	16.17%	1.55%	8.00%	8.52%	-	-10.67%
Effective Tax Rate	21.78%	45.66%	12.95%	-	-	-
Revenue as Reported	2,712	1,122	214.83	1.8	-	1.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.